The Hydration Pharmaceuticals Co (ASX:HPC) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is The Hydration Pharmaceuticals Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. The Hydration Pharmaceuticals Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

The Hydration Pharmaceuticals Co's long-term debt to total assets ratio declined from Dec. 2023 (0.58) to Dec. 2024 (0.00). It may suggest that The Hydration Pharmaceuticals Co is progressively becoming less dependent on debt to grow their business.

The Hydration Pharmaceuticals Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for The Hydration Pharmaceuticals Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Hydration Pharmaceuticals Co LT-Debt-to-Total-Asset Chart

The Hydration Pharmaceuticals Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

0.36

0.58

The Hydration Pharmaceuticals Co Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial			0.36	0.50	0.58	0.83	-

The Hydration Pharmaceuticals Co LT-Debt-to-Total-Asset Calculation

The Hydration Pharmaceuticals Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	0	/	7.889
	=	0.00

The Hydration Pharmaceuticals Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	0	/	7.889
	=	0.00

The Hydration Pharmaceuticals Co (ASX:HPC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

The Hydration Pharmaceuticals Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of The Hydration Pharmaceuticals Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

The Hydration Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » The Hydration Pharmaceuticals Co Ltd (ASX:HPC) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121

Website

https://www.hydralyte.com

The Hydration Pharmaceuticals Co Ltd is engaged in the marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States. Some of its products include Hydration + Immune System Boost, Effervescent Electrolyte Tablets, Oral Rehydration Solution, and Immunity Booster Bundle.

The Hydration Pharmaceuticals Co Headlines

No Headlines